Policy Brief

Our Policy Brief presents research in a clear, concise, and engaging format, designed to support high-level executives and policy decision-makers in using evidence-based information to inform effective policy development and implementation.
Policy Brief 62 issues
All (62)
btn-doc
Cost-Effectiveness of Cascade Testing for Familial Hypercholesterolemia in Thailand: A Comparative Analysis of Genome Sequencing Methods Across Development Stages
Issue No. 182
Cost-Effectiveness of Cascade Testing for Familial Hypercholesterolemia in Thailand: A Comparative Analysis of Genome Sequencing Methods Across Development Stages
By : Dr. Dimple Butani
btn-doc
Survey Results: What Do Thai People Think About Health Equity?
Issue No. 180
Survey Results: What Do Thai People Think About Health Equity?
By : Wanrudee Isaranuwatchai, PhD, Picharee Karunayawong, Chittawan Poonsiri
btn-doc
Strategies for Sustainable Access: Unpacking Managed Entry Agreements (MEAs) and Innovative Medicine Access
Issue No. 31
Strategies for Sustainable Access: Unpacking Managed Entry Agreements (MEAs) and Innovative Medicine Access
By : Dr. Dimple Butani
btn-doc
Unveiling Thailand’s Path to Open Data for Health Policy
Issue No. 29
Unveiling Thailand’s Path to Open Data for Health Policy
btn-doc
eSanjeevani, the National Telemedicine service: Bridging healthcare gaps in India
Issue No. 27
eSanjeevani, the National Telemedicine service: Bridging healthcare gaps in India
btn-doc
Implementation of a Virtual Consultation Platform (VCP) for Healthcare Providers Integrated with a Patient-Facing Mobile Application
Issue No. 28
Implementation of a Virtual Consultation Platform (VCP) for Healthcare Providers Integrated with a Patient-Facing Mobile Application
btn-doc
Rare diseases – Talk of the Town for Some Time but What’s Next?
Issue No. 26
Rare diseases – Talk of the Town for Some Time but What’s Next?
By : Phornnaphat Chertchinnapa, Annapoorna Prakash
btn-doc
South Korea’s Experience of Reimbursing High-Cost Medicines
Issue No. 25
South Korea’s Experience of Reimbursing High-Cost Medicines
By : Dr. Dimple Butani
btn-doc
Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
Issue No. 24
Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
By : Kumaree Pachanee, Dian Faradiba
btn-doc
Health Financing during COVID-19 responses in Thailand
Issue No. 149
Health Financing during COVID-19 responses in Thailand
By : Papada Ranron, Praewa Kulatnam, Aungsumalee Pholpark, Sikarn lssarachaiyos
btn-doc
Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs
Issue No. 23
Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs
By : Dian Faradiba
btn-doc
Horizon Scanning in the European Union
Issue No. 22
Horizon Scanning in the European Union
By : Dian Faradiba, Dr. Dimple Butani, Mr. Nyi Nyi Zayar
12 / Pages